CDH26 amplifies airway epithelial IL-4 receptor α signaling in asthma
Preprint
Abstract
Background: Activation of interleukin (IL)-4 receptor (R) signaling in airway epithelial cells leads to airway hyperresponsiveness and mucus overproduction in asthma. Cadherin-26 (CDH26), a cadherin implicated in polarization of airway epithelial cells, is upregulated in asthma. However, the role of CDH26 in asthma remains unknown. We hypothesize that CDH26 plays a role in airway epithelial IL-4R signaling in asthma. Methods: We measured airway resistance, mucus production, airway inflammation, and Il-4Rα expression in Cdh26 -/- and WT mice after allergen sensitization and challenge. We explored the role of CDH26 in IL-4R signaling, mucin genes and eosinophilic chemokine expression in cultured bronchial epithelial cells and bronchial brushings from asthma patients. Results: Cdh26 deficiency nearly blocked airway mucus overproduction, and suppressed AHR and airway eosinophilia in a murine model of allergic airway disease. Interestingly, Il-4Rα expression in airway epithelium was markedly reduced in Cdh26 -/- mice. In cultured human bronchial epithelial cells, CDH26 knockdown inhibited IL-13, a ligand for IL-4R, -induced IL-4Rα and IL-13Rα1 expression, and suppressed the downstream Jak1 and Stat6 phosphorylation. Moreover, CDH26 knockdown inhibited IL-13-induced MUC5AC, MUC5B and eosinophilic chemokines CCL11, CCL24, CCL26 expression. In contrast, CDH26 overexpression intensified IL-13-induced activation of IL-4Rα signaling. In asthma patients, CDH26 was the only one upregulated of 11 cadherins in bronchial brushings. CDH26 expression significantly correlated with epithelial IL-4Rα, MUC5AC expression, sputum eosinophilia and fractional exhaled nitric oxide (FeNO). Conclusion: Taken together, CDH26 is an amplifier of epithelial IL-4R signaling in asthma, and may represent a therapeutic target for airway mucus overproduction.Keywords
All Related Versions
- Published version: American Journal of Respiratory Cell and Molecular Biology, 67 (5), 539.
This publication has 43 references indexed in Scilit:
- IL-4Rα expression by airway epithelium and smooth muscle accounts for nearly all airway hyperresponsiveness in murine allergic airway diseaseMucosal Immunology, 2019
- AsthmaThe Lancet, 2018
- IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathwayPulmonary Pharmacology & Therapeutics, 2017
- Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthmaJournal of Allergy and Clinical Immunology, 2014
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Interleukin-4, Interleukin-13, Signal Transducer and Activator of Transcription Factor 6, and Allergic AsthmaCurrent Molecular Medicine, 2008
- Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesisProceedings of the National Academy of Sciences, 2008
- Helminth regulation of host IL-4Rα/Stat6 signaling: Mechanism underlying NOS-2 inhibition byTrichinella spiralisProceedings of the National Academy of Sciences, 2005
- Signal Transducer and Activator of Transcription Factor 6 (Stat6)-deficient Mice Are Protected from Antigen-induced Airway Hyperresponsiveness and Mucus ProductionJournal of Experimental Medicine, 1998